Literature DB >> 7490142

Diabetes mellitus and associated hypertension, vascular disease, and nephropathy. An update.

J R Sowers1, M Epstein.   

Abstract

Because considerable important information has been published since our previous review, this update concentrates on new findings with regard to cardiovascular and renal risk factors contributing to the striking morbidity and mortality of these coexisting diseases. For example, a large body of investigative data has recently emerged suggesting or delineating a pathogenic role for hyperglycemic-related glycosylation and oxidation of lipoproteins and vascular and renal tissues. Great strides have recently been made in the understanding of platelet, coagulation, lipoprotein, and endothelial abnormalities in the pathogenesis of cardiovascular and renal disease associated with diabetes mellitus and hypertension. Major progress has been made in clarifying the pathophysiology of glomerulosclerosis and other processes involved in the progression of diabetic nephropathy. Furthermore, accumulating data surveyed in this review address new and promising pharmacological interventions that specifically address these pathophysiological mechanisms.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7490142     DOI: 10.1161/01.hyp.26.6.869

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  71 in total

Review 1.  Obesity, hypertension, and vascular disease.

Authors:  K M Sowers; J R Sowers
Journal:  Curr Hypertens Rep       Date:  1999 Apr-May       Impact factor: 5.369

2.  Insulin therapy, hyperglycemia, and hypertension in type 1 diabetes mellitus.

Authors:  Ian H de Boer; Bryan Kestenbaum; Tessa C Rue; Michael W Steffes; Patricia A Cleary; Mark E Molitch; John M Lachin; Noel S Weiss; John D Brunzell
Journal:  Arch Intern Med       Date:  2008-09-22

Review 3.  Effect of citrus flavonoids, naringin and naringenin, on metabolic syndrome and their mechanisms of action.

Authors:  M Ashraful Alam; Nusrat Subhan; M Mahbubur Rahman; Shaikh J Uddin; Hasan M Reza; Satyajit D Sarker
Journal:  Adv Nutr       Date:  2014-07-14       Impact factor: 8.701

4.  Gene therapy in diabetes.

Authors:  Mary S Wong; Wayne J Hawthorne; Nicholas Manolios
Journal:  Self Nonself       Date:  2010-06-09

5.  Factor V Leiden mutation and Japanese NIDDM.

Authors:  M Odawara; K Yamashita
Journal:  Diabetologia       Date:  1997-11       Impact factor: 10.122

Review 6.  Drug treatment of hypertension complicating diabetes mellitus.

Authors:  M J MacLeod; J McLay
Journal:  Drugs       Date:  1998-08       Impact factor: 9.546

Review 7.  Percutaneous versus surgical interventions for coronary artery disease in those with diabetes mellitus.

Authors:  Ozlem Soran
Journal:  Curr Cardiol Rep       Date:  2013-01       Impact factor: 2.931

8.  Administration of a substituted adamantyl urea inhibitor of soluble epoxide hydrolase protects the kidney from damage in hypertensive Goto-Kakizaki rats.

Authors:  Jeffrey J Olearczyk; Jeffrey E Quigley; Bradford C Mitchell; Tatsuo Yamamoto; In-Hae Kim; John W Newman; Ayala Luria; Bruce D Hammock; John D Imig
Journal:  Clin Sci (Lond)       Date:  2009-01       Impact factor: 6.124

Review 9.  Hypertension management in patients with diabetic nephropathy.

Authors:  Anthony L McCall
Journal:  Curr Hypertens Rep       Date:  2004-08       Impact factor: 5.369

10.  Morbidity in relation to stage of diabetic nephropathy in type-2 diabetic patients.

Authors:  Christopher Olutayo Alebiosu; Olatunde Odusan; Alfred Jaiyesimi
Journal:  J Natl Med Assoc       Date:  2003-11       Impact factor: 1.798

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.